Vanta Bioscience bulk deals, insider trading and stake changes
BSE: 540729Healthcare ServicesSmall Cap
Share price at the BSE close on 16 Oct 2026. Previous close ₹20.42.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies.
- ₹15 Cr4,396th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. The filing of 30 May 2026
- 134.0
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. The filing of 30 May 2026
- 0.7
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it. The filing of 30 May 2026
- 0.7%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026. The filing of 30 May 2026
- 1.80
- Volume, BSEVolume. Shares traded on the last trading day.
- 1,500
Vanta Bioscience insider trading
All 7 disclosures on record. The company's own latest disclosure on record is from May 2025.Insider trading, all companies
May 2025
- Dopesh Raja Mulakala₹2.00 Cr4,00,000 sharesReceived · Promoter and Director · 6 May 2025 · disclosed 7 May · Preferential Offer · held 4,58,000 before, holds 8,58,000 after
- S Chandra Sekhar Rao₹2.00 Cr4,00,000 sharesReceived · Promoter · 6 May 2025 · disclosed 7 May · Preferential Offer · held 1,22,500 before, holds 5,22,500 after
Jun 2022
- CHANDRA SHEKAR RAO SIMHADRI₹0.05 Cr5,250 sharesBought · Promoter · 21 Jun 2022 · disclosed 23 Jun · stake 1.74% before, 1.82% after
- CHANDRA SHEKAR RAO SIMHADRI₹0.09 Cr9,750 sharesBought · Promoter · 16 Jun 2022 · disclosed 20 Jun · stake 1.58% before, 1.74% after
Apr 2021
- Pradeep Chowdary Veeramachineni₹0.11 Cr6,750 sharesSold · Promoter · 1 Apr 2021 · disclosed 19 Apr · stake 0.45% before, 0.34% after
Nov 2020
- Pradeep Chowdary Veeramachineni₹0.84 Cr51,750 sharesSold · Promoter · 13 Nov 2020 · disclosed 19 Apr 2021 · stake 1.27% before, 0.45% after
Nov 2018
- Dopesh Raja Mulakala₹2.24 Cr2,64,000 sharesReceived · Promoter & Director · 28 Nov 2018 · disclosed 29 Nov · Preferential Offer · held 1,94,000 before, holds 4,58,000 after
Trades by the company's promoters, directors, key managers, employees and their relatives, as each disclosed them. Value is what the filer stated; the mode is shown where the shares moved off the market.
Vanta Bioscience stake sales and purchases
All 2 disclosures on record.
May 2025
- AcquiredDopesh Raja Mulakala & Others · promoter12.68% of the company8,00,000 sharesholds 72.81% after6 May 2025 · filed under the 2% rule · Preferential allotment
Nov 2018
- AcquiredDopesh Raja Mulakala · promoter4.61% of the company2,64,000 sharesholds 7.26% after28 Nov 2018 · filed under the 2% rule · Preferential allotment
The 5% rule: an investor discloses on reaching 5% of the company. The 2% rule: a holder of 5% or more discloses each change of 2% or more, including one that takes it below 5%. A transfer exempt from an open offer, the offer to buy from every other shareholder that a large purchase otherwise brings, is disclosed too. Each line shows what its filing states, which can be a smaller change than its rule names.
Vanta Bioscience bulk deals
None in the last 12 months, since 24 Oct 2025.Today's bulk and block deals, all companies
ValueValue of a deal. The shares traded times the deal's price.Per cent of the companyPer cent of the company. The shares traded as a percentage of all the company's shares in issue on the day of the deal.
Thursday 13 Mar 20252 firms · ₹0.20 Cr bought · ₹0.20 Cr soldNet nil
- SoldBOSCO ARMANDO MENEZESSold 63,750 at ₹30.751.01% of the company₹0.20 Cr
- BoughtEMILY BOSCO MENEZESBought 63,750 at ₹30.751.01% of the company₹0.20 Cr
Monday 25 Jun 20181 firm · ₹0 bought · ₹0.30 Cr soldNet sold ₹0.30 Cr
- SoldINVENTURE GROWTH & SECURITIES LTD.Sold 63,000 at ₹48.131.10% of the company₹0.30 Cr
Wednesday 25 Oct 20175 firms · ₹0.91 Cr bought · ₹2.36 Cr soldNet sold ₹1.45 Cr
- SoldINVENTURE GROWTH & SECURITIES LTD.Sold 3,84,000 at ₹52.69₹2.02 Cr
- BoughtSACHIN BHUWALKA (HUF)Bought 81,000 at ₹53.83₹0.44 Cr
- SoldKANCHUSTAMBHAM TRILEKHASold 54,000 at ₹59.21₹0.32 Cr
- BoughtM REKHABought 57,000 at ₹50.90₹0.29 Cr
- Both waysNISHAJAYESHCHOKSHIBought 30,000 at ₹59.75Sold 3,000 at ₹54.30Net +27,000 shares₹0.18 Cr bought
Tuesday 24 Oct 20173 firms · ₹0.29 Cr bought · ₹0.56 Cr soldNet sold ₹0.27 Cr
- SoldINVENTURE GROWTH & SECURITIES LTD.Sold 69,000 at ₹53.79₹0.37 Cr
- BoughtS S SEEMABought 54,000 at ₹54.36₹0.29 Cr
- SoldS N SRINIVASA MURTHYSold 36,000 at ₹52.96₹0.19 Cr
Monday 23 Oct 20171 firm · ₹0 bought · ₹0.18 Cr soldNet sold ₹0.18 Cr
- SoldINVENTURE GROWTH & SECURITIES LTD.Sold 36,000 at ₹49.43₹0.18 Cr
Friday 13 Oct 20172 firms · ₹0.25 Cr bought · ₹0.26 Cr soldNet sold ₹0.01 Cr
- SoldINVENTURE GROWTH & SECURITIES LTD.Sold 54,000 at ₹48.97₹0.26 Cr
- BoughtKANCHUSTAMBHAM TRILEKHABought 51,000 at ₹48.95₹0.25 Cr
Friday 6 Oct 20171 firm · ₹0.37 Cr bought · ₹0 soldNet bought ₹0.37 Cr
- BoughtINVENTURE GROWTH & SECURITIES LTD.Bought 72,000 at ₹51.10₹0.37 Cr
A bulk deal is one client trading half a per cent or more of the shares in a day; a block deal is a large trade in the exchange's separate block window, its buyer and its seller each on a line of their own. A firm that bought and sold the shares the same day is on one line, with its net. All 15 deals on record since listing on 6 Oct 2017.